On Monday, Shares of Inovio Pharmaceuticals Inc (NASDAQ:INO), subtract -4.57% and closed at 8.15 in the last trading session. The last trading range of the stock ranges between $7.94 and 8.54. Inovio Pharmaceuticals, Inc. (INO) recently declared planned leadership appointments to support the advancement of its portfolio of DNA-based cancer immunotherapies and infectious disease vaccines. Inovio has an extensive pipeline of clinical-stage cancer immunotherapies highlighted by VGX-3100, which is entering phase III this year; and DNA vaccines in development for Zika, MERS and HIV, among others.
Inovio adds two oncologists and a plasmid manufacturing expert reporting to Inovio’s Chief Medical Officer, Dr. Mark Bagarazzi:
Dr. Ildiko Csiki will serve Inovio as Vice President, Clinical Development, Oncology, responsible for advancing Inovio’s cancer programs. Before joining Inovio, Dr. Csiki had been clinical lead and senior director of clinical research at Merck & Co. where she guided Merck’s global solid tumor development program and was lead for several registration studies. Dr. Csiki also served as GSK’s director of clinical development and lead physician for the follicular lymphoma program. Dr. Csiki earned her MD and PhD degrees from Vanderbilt University School of Medicine and her BS in Biology and BA in Psychology from the University of Arkansas.
Dr. Jeffrey Skolnik, Vice President, Clinical Development, Oncology, will also direct Inovio’s cancer immunotherapy programs. Dr. Skolnik was formerly vice president of clinical research at TetraLogic Pharmaceuticals, where he oversaw all global clinical assets. He also served as a medical director at GSK and AstraZeneca. Dr. Skolnik earned his MD at New York University, with honors in pathology, and his undergraduate degree from the University of Pennsylvania.
Berry Plastics Group Inc (NYSE:BERY), jumped 0.22% and closed at $44.60 in the last trading session. The last trading range of the stock ranges between 44.48 and 44.92. The company’s Market capitalization is $5.50 Billion with the total Outstanding Shares of 121.60 million. Berry Plastics Group, Inc. manufactures and distributes plastic consumer packaging and engineered materials in the United States, Canada, Mexico, Belgium, France, Australia, Germany, Brazil, Malaysia, India, China, and the Netherlands. The company operates through three segments: Health, Hygiene and Specialties; Consumer Packaging; and Engineered Materials. It offers rigid packaging products, counting containers; foodservice products, such as thermoformed polypropylene and injection-molded plastic drink cups; closures and over caps comprising continuous-thread and child-resistant closures, in addition to aerosol over caps; bottle and prescription containers; and extruded and laminate tubes. The company also provides engineered materials, counting corrosion protection products; and cloth and foil, splicing and laminating, flame-retardant, vinyl-coated and carton sealing, electrical, double-faced cloth, masking, mounting, OEM, and medical and specialty tapes. The companys engineered materials also consists of drop cloths and retail trash bags; polyvinyl chloride films and boxed products; trash-can liners and food bags; and stretch and shrink films. In addition, it offers flexible packaging products, such as personal care films; food and consumer films, in addition to barrier films; and converter films, counting coated and laminated products, in addition to a range of products for the food, healthcare, and personal care markets.